<DOC>
	<DOCNO>NCT00084435</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy , cisplatin docetaxel , work different way stop tumor cell divide stop grow die . Radiation therapy use high-energy x-rays damage tumor cell . Cisplatin docetaxel may make tumor cell sensitive radiation therapy . Giving chemoradiotherapy surgery may kill remain tumor cell . PURPOSE : This phase II trial study well adjuvant chemoradiotherapy use cisplatin docetaxel work treat patient completely resect stage III stage IV head neck cancer .</brief_summary>
	<brief_title>S0217 , Adjuvant Cisplatin Docetaxel After Complete Resection Stage III IV Head Neck Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine disease-free survival overall survival patient high-risk stage III IV squamous cell carcinoma head neck treat adjuvant chemoradiotherapy comprise docetaxel cisplatin . - Determine toxicity regimen patient . - Categorize site ( ) disease relapse patient treat regimen . OUTLINE : This multicenter study . Patients receive docetaxel IV 1 hour day 1 , 8 , 15 , 22 , 29 , 36 cisplatin IV 1.5 hour day 1 , 22 , 43 . Patients undergo radiotherapy daily day 1-5 , 8-12 , 15-19 , 22-26 , 29-33 , 36-40 , 43-45 . Treatment continue absence disease progression unacceptable toxicity . Patients follow every 3 month disease progression every 6 month 3 year registration . PROJECTED ACCRUAL : A total 70 patient accrue study within 17.5-23.5 month .</detailed_description>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis squamous cell carcinoma head neck Selected stage III IV ( distant metastasis ) disease The following TNM stage exclude : T3 , N0 , M0 T4a , N0 , M0 T4b , N3 , M0 Any T , N , M1 Complete total resection within past 56 day AND one follow risk factor : Multiple pathologically confirm lymph node metastases One lymph nod extracapsular extension tumor Microscopically positive margin ( ) resection , include mucosal margin and/or soft tissue deep margin resection No primary nasopharyngeal carcinoma PATIENT CHARACTERISTICS : Age 18 Performance status Zubrod 01 Life expectancy Not specify Hematopoietic Absolute neutrophil count ≥ 1,500/mm^3 Platelet count ≥ 100,000/mm^3 Hemoglobin ≥ 8.0 g/dL Hepatic Bilirubin ≤ 2 time upper limit normal ( ULN ) SGOT SGPT ≤ 1.5 time ULN Alkaline phosphatase ≤ 2.5 time ULN Renal Creatinine ≤ 1.5 mg/dL OR Creatinine clearance ≥ 60 mL/min Other No preexist peripheral neuropathy No known history severe hypersensitiviy reaction product contain Polysorbate 80 No malignancy within past 5 year except adequately treat basal cell squamous cell skin cancer , carcinoma situ cervix , adequately treated stage I II cancer currently complete remission Not pregnant nursing Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy No prior chemotherapy malignancy Endocrine therapy Not specify Radiotherapy No prior radiotherapy malignancy Surgery See Disease Characteristics Other No concurrent amifostine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>stage III squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage IV squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage III squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>stage IV squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>stage III salivary gland cancer</keyword>
	<keyword>stage IV salivary gland cancer</keyword>
	<keyword>stage III squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage III squamous cell carcinoma larynx</keyword>
	<keyword>stage IV squamous cell carcinoma larynx</keyword>
	<keyword>stage III squamous cell carcinoma oropharynx</keyword>
	<keyword>stage IV squamous cell carcinoma oropharynx</keyword>
	<keyword>salivary gland squamous cell carcinoma</keyword>
</DOC>